Sirona Dx is a technical Contract Research Organization (CRO) based in Lake Oswego, Oregon. Founded in 2016, their mission is to accelerate the development of immunotherapy and targeted therapy through innovative single cell proteomics and genomics services. They offer leading-edge technologies and deep technical expertise to assist life science companies in product development, from platform selection to assay design and optimization. With a focus on precision medicine, Sirona Dx aims to advance exploratory biomarker programs and provide safer and more effective treatment solutions.
As pioneers in spatial biology technology, Sirona Dx launched the first spatial-omics CRO service in 2018, utilizing IMC technology developed by Fluidigm. They also provide access to the latest spatial multiomics 3D imaging technology from Nanostring and the COMET platform from Lunaphore, making them the first CRO in North America to do so. With their CLIA accredited laboratory, Sirona Dx supports pharma regulatory requirements and offers a range of services, including imaging mass cytometry, immune profiling, IO expression assays, histopathology, and COVID-19 testing. Their team is committed to partnering with biopharma companies every step of the way, from exploratory testing and biomarker development to clinical trials support.
Generated from the website